izpis_h1_title_alt

Antiphospholipid syndrome in children
ID Zajc Avramovič, Mojca (Author), ID Avčin, Tadej (Author)

.pdfPDF - Presentation file, Download (1,07 MB)
MD5: 14F741FFE023363B2C9D900A5E1F65A7
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S1521694224000573 This link opens in a new window

Abstract
Antiphospholipid syndrome (APS) in children is a rare disease associated with significant morbidity and mortality. In comparison with APS in adults, pediatric APS has a more severe presentation with frequent recurrences of thrombotic events and a higher probability of life-threatening catastrophic APS. Nonthrombotic manifestations are also more common in the pediatric age group and can precede thrombosis. New classification criteria have been introduced recently and have not yet been assessed in pediatric patients with APS. In addition to anticoagulation drugs, other novel therapies have emerged including the use of B cell and complement inhibitors, especially in catastrophic APS. The purpose of this review is to provide a broad overview of aPL-related clinical manifestations in pediatric patients based on the analysis of published cohorts and data from the international pediatric APS registry. We also aim to illustrate APS in infants caused by transplacentally transferred maternal aPL, which is very rarely associated with acute thrombotic events in the perinatal period and more frequently with long-term neurodevelopmental abnormalities.

Language:English
Keywords:catastrophic antiphospholipid syndrome, children, infants antiphospholipid syndrome, systemic lupus erythematosus, antiphospholipid antibodies, thrombosis, thrombocytopenia, chorea, lupus anticoagulants, anticardiolipin antibodies, anti-β2 glycoprotein I antibodies
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:15 str.
Numbering:Vol. 38, iss. 3, art. 101986
PID:20.500.12556/RUL-162552 This link opens in a new window
UDC:61
ISSN on article:1532-1770
DOI:10.1016/j.berh.2024.101986 This link opens in a new window
COBISS.SI-ID:204888323 This link opens in a new window
Publication date in RUL:25.09.2024
Views:55
Downloads:11
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Baillière's best practice and research in clinical rheumatology
Shortened title:Baillière's best pract. res. clin. rheumatol.
Publisher:Elsevier
ISSN:1532-1770
COBISS.SI-ID:204885507 This link opens in a new window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-3061
Name:Klinične, imunološke in genetske značilnosti večorganskega vnetnega sindroma, povezanega s COVID-19, pri otrocih in mladostnikih

Funder:Other - Other funder or multiple funders
Funding programme:University Medical Centre Ljubljana
Project number:20210069

Funder:Other - Other funder or multiple funders
Funding programme:University Medical Centre Ljubljana
Project number:20220090

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back